Pompeo: ‘Enormous Evidence’ Coronavirus Originated in

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
796
Pompeo: ‘Enormous Evidence’ Coronavirus Originated in Wuhan Lab
< >

Sunday on ABC’s “This Week” Secretary of State Mike Pompeo said there was “enormous evidence” that coronavirus originated in the Wuhan lab and not a wet market, as some have suspected.

Partial transcript as follows:

RADDATZ: I want to turn to China, with intelligence officials, as we mentioned, saying that the Chinese government intentionally concealed the severity of COVID-19 from the international community in early January, while it stockpiled medical supplies.

In terms of international concealing, I assume you think they did that intentionally to keep as many masks for themselves as possible. Will there be some sort of retaliation?

POMPEO: Martha, you’ve got the facts just about right. We can confirm that the Chinese Communist Party did all that it could to make sure that the world didn’t learn in a timely fashion about what was taking place.

There’s lots of evidence of that. Some of it you can see in public, right?

We’ve seen announcements. We’ve seen the fact that they kicked the journalists out. We saw the fact that those who were trying to report on this, medical professionals inside of China, were silenced. They shut down reporting — all the kind of things that authoritarian regimes do, the way Communist parties operate. This is a classic Communist disinformation effort. That created enormous risk, and now you can see hundreds of thousands of people around the world, tens of thousands in the United States, have been harmed. President Trump has been very clear. We’re going to hold those responsible accountable, and we’ll do so on a timeline that is our own.

RADDATZ: And — and as for the origins of COVID-19, the Office of the Director of National Intelligence released a statement this week saying the virus did originate in China, but concurs with the wide scientific consensus that the COVID-19 virus was not man-made or genetically modified, the statement going on to say that they will continue to examine whether the outbreak began through contact with infected animals or if it was the result of an accident in a laboratory in Wuhan. Later, the president was asked if he had seen anything that gave him high confidence that the Wuhan lab was the origin of the virus. Let’s listen.

(BEGIN VIDEO CLIP)

QUESTION: Have you seen anything at this point that gives you a high degree of confidence that the Wuhan Institute of Virology was the origin of this virus?

TRUMP: Yes, I have. Yes, I have.

QUESTION: What gives you a high degree of confidence that this originated from the Wuhan Institute of Virology?

TRUMP: I can’t tell you that. I’m not allowed to tell you that.

(END VIDEO CLIP)

RADDATZ: And, Mr. Secretary, have you seen anything that gives you high confidence that it originated in that Wuhan lab?

POMPEO: Martha, there’s enormous evidence that that’s where this began. We’ve said from the beginning that this was a virus that originated in Wuhan, China. We took a lot of grief for that from the outset. But I think the whole world can see now.

Remember, China has a history of infecting the world, and they have a history of running substandard laboratories. These are not the first times that we’ve had a world exposed to viruses as a result of failures in a Chinese lab.

And so, while the intelligence community continues to do its work, they should continue to do that, and verify so that we are certain, I can tell you that there is a significant amount of evidence that this came from that laboratory in Wuhan.

RADDATZ: Do you believe it was man-made or genetically modified?

POMPEO: Look, the best experts so far seem to think it was man-made. I have no reason to disbelieve that at this point.

RADDATZ: Your — your Office of the DNI says the consensus, the scientific consensus was not man-made or genetically modified.

POMPEO: That’s right. I agree with that. Yeah. I’ve seen their analysis. I’ve seen the summary that you saw that was released publicly. I have no reason to doubt that that is accurate…

(CROSSTALK)

RADDATZ: OK, so just to be clear, you do not think it was man-made or genetically modified?

POMPEO: I’ve seen what the intelligence community has said. I have no reason to believe that they’ve got it wrong.

(CROSSTALK)

POMPEO: Martha, you have to put this in context. Here’s what — here’s what’s important, Martha. Here’s what’s important. The Chinese Communist Party had the opportunity to prevent all of the calamity that has befallen the world. And here we find ourselves today — you and I were talking about we haven’t seen each other physically for a long time. That’s true of people all across the world.

This — this is an enormous crisis, created by the fact that the Chinese Communist Party reverted to form, reverted to the kinds of disinformation, the kinds of concealment that authoritarian regimes. Had those scientists been operating in America, they would have put this out. There would have been an exchange of ideas. And we would have quickly identified the kinds of things that needed to be done in response.

Instead, China behaved like authoritarian regimes do, attempted to conceal and hide and confuse. It employed the World Health Organization as a tool to do the same. These are the kind of things that have now presented this enormous crisis, an enormous loss of life and tremendous economic cost, all across the globe. The Australians agree with that. You hear the Europeans beginning to say the same thing. I think the whole world is united in understanding that China brought this virus to the world.

RADDATZ: And — and, just very quickly, if we can, Mr. Secretary, running out of time. Do you think they intentionally released that virus or it was an accident in the lab?

POMPEO: You know, I don’t have anything to say about that. I think there’s a lot to know. But I can say this. We’ve done our best to try and answer all of those questions. We tried to get a team in there. The World Health Organization tried to get a team in there. And they have failed. No one’s been allowed to go to this lab or any of the other laboratories — there are many labs inside of China, Martha. This risk remains. This is an ongoing challenge. We still need to get in there. We still don’t have the virus samples we need. This is an ongoing threat, an ongoing pandemic. And the Chinese Communist Party continues to block access to the Western world, the world’s best scientists, to figure out exactly what happened. So I can’t answer your question about that. Because the Chinese Communist Party has refused to cooperate with world health experts.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Labcorp Lifts 2026 Guidance Amid Strong Q3 Performance

Updated Category News Views 80

Labcorp's Q3 Numbers Speak Loud and Clear Another quarter, another robust set of numbers for Labcorp (NYSE:LH). The company is strutting into the spotlight with third-quarter 2026 results that have investors nodding in approval. Revenue surged to $3.81 billion, marking a 6.9% increase from the prior year's $3.56 billion. And get this: adjusted EPS jumped 14.5%, clocking...

Continue Reading
SoftwareOne Triumphs in 2026 GitHub Partner Awards

Updated Category News Views 43

SoftwareOne Nabs Prestigious GitHub Honor Outta nowhere, SoftwareOne's been lashed onto the center stage, bagging GitHub's Global Channel Sales Partner of the Year for 2026. This ain't just another shiny trophy on the shelf; it's a solid nod to their grit and strategy. Now, if good old GitHub says you're their top dog, you're obviously doing something right. Not bad for a...

Continue Reading
AppLovin Faces Class Action: AI Growth Claims Under Fire

Updated Category News Views 14

AppLovin's AI Jackpot: A Busted Flush? This year's been a rollercoaster at AppLovin Corporation, and not the fun kind. Let me tell ya, investors bought into a dream—a self-sustaining, profit-churning machine based on AI advertising models. Unfortunately, reality came around like a bad penny, and suddenly, their 'virtuous cycle' feels more like a busted flush....

Continue Reading
HERVolution's HERV-K Antigens: A Cancer Breakthrough?

Updated Category News Views 0

Digging into HERVolution's Game-Changing Data Picture HERVolution in the spotlight, rolling out data that could shake up our approach to cancer immunotherapy. The big headline? HERV-K antigens might just be the whistle-blower we've been looking for to get the immune system off the bench and onto the field. How's that for a kick in the conventional wisdom of cancer...

Continue Reading
QFIN Faces Lawsuit Over Broken Promises and Revenue Plunge

Updated Category News Views 35

Unmasking the Hype: QFIN's Pledge and Performance Investors, gather 'round because QFIN's latest uproar ain't pretty. The folks over at Qfin Holdings have found themselves in hot water, facing a class action lawsuit for allegedly pulling the wool over investors' eyes. Between March and August 2026, they promised a rock-solid ship braving China’s regulatory storm. Turns...

Continue Reading
Lynk Pharmaceuticals' Zemprocitinib Shines in Phase III RA Trial

Updated Category News Views 112

A Deep Dive into Lynk Pharmaceuticals' Latest Revelation Lynk Pharmaceuticals just dropped a bombshell with their latest Phase III trial results for zemprocitinib. This selective JAK1 inhibitor seems to be bringing some serious game in the fight against moderate-to-severe rheumatoid arthritis (RA), especially for folks who haven't had much luck with biologics. The drug...

Continue Reading
Faith on Trial: La Luz del Mundo Faces Court Ruling

Updated Category News Views 21

A Legal Battle Over Religious Freedom When folks start talking about religion intertwining with law, things get real tricky, real quick. The La Luz del Mundo church is knee-deep in such a legal tussle. On October 28, 2026, the United States District Court for the Southern District of New York gave a nod to the prosecution, denying the church's pretrial motions. What we've...

Continue Reading
Corgi Insurance Eyes $100B Auto Market with New Launch

Updated Category News Views 194

Leaping Into a Booming Market Well, it looks like someone lit a fire under Corgi Insurance, and they're ready to chase bigger bones. They’ve just rolled out a product called Corgi Business Auto, signaling quite a bold move into the hefty, nearly $100 billion U.S. commercial auto insurance arena. Now, as an old hand at this game, my ears perk up whenever I see a player...

Continue Reading
Pave and Levels.fyi Unite: Revolutionize Pay Decisions

Updated Category News Views 0

Diving straight into the heart of it, here's a move in the business world that's all but marking its territory on the compensation landscape. Pave, already a big player in agentic compensation management, is shaking hands with Levels.fyi, a platform prized for its real-deal compensation data detailed down to the company, level, location, and skill. These folks are...

Continue Reading
Honeywell Aerospace Posts Solid Q3, Raises Guidance

Updated Category News Views 39

Honeywell Aerospace Surprises with Strong Third Quarter In a world where numbers are often as slippery as a greased pig, Honeywell Aerospace (NASDAQ:HONA) has managed to pin down a surprisingly robust third quarter. Let’s break it down: they’ve claimed sales of a cool $4.6 billion, reflecting a 2% bump both in reported and organic revenue from the previous year, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Pyxis Oncology Focuses on Breakthrough Therapy PYX-201

Updated Category News Views 205

Pyxis Oncology Redirects Focus to Leading Therapy PYX-201 Pyxis Oncology, Inc. (NASDAQ:PYXS), a clinical-stage biotech firm, has announced a significant shift in its strategic direction by prioritizing its lead clinical program, PYX-201. This innovative antibody-drug conjugate (ADC) is engineered to target specific components within the tumor extracellular matrix, aiming...

Continue Reading
Ecovyst's Q3 Performance and Strategic Moves for Growth

Updated Category News Views 98

Ecovyst's Third Quarter Performance and Strategic Insights Ecovyst Inc. (NYSE: ECVT), a notable provider in the chemical industry, recently revealed its financial performance for the third quarter of 2025, showcasing significant progress in its operations and strategic decisions. The company specializes in the production of virgin sulfuric acid and regeneration services,...

Continue Reading
Consumer Interest Grows for Monthly AI Home Assistant Services

Updated Category News Views 447

Consumer Willingness to Invest in AI-Driven Home Solutions Recent research into consumer preferences reveals that a significant portion of the population is ready to embrace AI-assisted smart home technology. Parks Associates' compelling study finds that between 42% and 52% of consumers are inclined to subscribe to a monthly service for an AI smart home assistant that...

Continue Reading
Tuya Smart Introduces Hey Tuya: Revolutionizing Everyday AI Assistants

Updated Category News Views 186

Tuya Smart Unveils Hey Tuya: A Game-Changer in AI Technology In a notable advancement in AI technology, Tuya Smart (NYSE: TUYA) has introduced its innovative platform called Hey Tuya. This next-generation Super AI Life Assistant is set to redefine how individuals interact with artificial intelligence in their daily lives. The initiative represents a significant leap...

Continue Reading
Innovative Food Packaging Concept Redefines Convenience

Updated Category News Views 384

New Approach to Food and Beverage Packaging In an ever-evolving world where efficiency and convenience are paramount, an inventive solution has emerged. An inventor, motivated by the challenges of transporting, preparing, and storing food, has conceptualized an improved packaging design that promises to revolutionize these everyday tasks. Why This Invention Matters This...

Continue Reading